- Home
- YMAB vs FDBC Comparison
YMAB vs FDBC Comparison
Compare YMAB & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- FDBC
- Stock Information
- Founded
- YMAB 2015
- FDBC 1902
- Country
- YMAB United States
- FDBC United States
- Employees
- YMAB N/A
- FDBC N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- YMAB Health Care
- FDBC Finance
- Exchange
- YMAB Nasdaq
- FDBC Nasdaq
- Market Cap
- YMAB 218.4M
- FDBC 226.2M
- IPO Year
- YMAB 2018
- FDBC N/A
- Fundamental
- Price
- YMAB $4.04
- FDBC $41.43
- Analyst Decision
- YMAB Buy
- FDBC
- Analyst Count
- YMAB 11
- FDBC 0
- Target Price
- YMAB $18.73
- FDBC N/A
- AVG Volume (30 Days)
- YMAB 204.4K
- FDBC 6.2K
- Earning Date
- YMAB 05-13-2025
- FDBC 04-23-2025
- Dividend Yield
- YMAB N/A
- FDBC 3.86%
- EPS Growth
- YMAB N/A
- FDBC 32.67
- EPS
- YMAB N/A
- FDBC 3.76
- Revenue
- YMAB $87,685,000.00
- FDBC $81,621,000.00
- Revenue This Year
- YMAB N/A
- FDBC N/A
- Revenue Next Year
- YMAB $18.83
- FDBC N/A
- P/E Ratio
- YMAB N/A
- FDBC $11.00
- Revenue Growth
- YMAB 3.38
- FDBC 15.50
- 52 Week Low
- YMAB $3.84
- FDBC $37.00
- 52 Week High
- YMAB $17.47
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- YMAB 42.87
- FDBC 52.51
- Support Level
- YMAB $4.02
- FDBC $40.54
- Resistance Level
- YMAB $4.60
- FDBC $43.10
- Average True Range (ATR)
- YMAB 0.32
- FDBC 1.25
- MACD
- YMAB -0.01
- FDBC 0.41
- Stochastic Oscillator
- YMAB 23.93
- FDBC 72.62
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.